Evaluation the efficacy of Achillea wilhelmsii capsule in irritable bowel syndrome patients:a randomized double blind placebo controlled clinical trial

Vice – Chancellery of Research, Kermanshah University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Inclusion criteria : age>18 ; ability to swallow the capsule ; patients who sign the testimonials and cooperate during the study ; patients who are not cured with Achillea wilhelmsii during a last month ; Patients who their diseases are approved by complete medical evaluation.
•Exclusion criteria : pregnant patients and nursing mothers ; patients with any active stomach-interic disease ; patients who have to use other drugs that interference with this medication (such as laxative? antidepressants? opioid and narcotic analgesics ) ; patients who are disposed to a serious health danger, such as severe cardiac, liver or renal diseases ; If significant side effects occur, the patient will be excluded from the study ; patients with severe allergy to this plant (dermatitis contact) will be excluded.

发起方

Vice – Chancellery of Research, Kermanshah University of Medical Sciences